Abstract
Several cell-based therapeutic options to treat musculoskeletal injuries in horses are commercially available. The current literature supports the use of cell-based therapies to treat equine musculoskeletal injuries. Researchers continue to search for more effective cell-based therapies to provide practitioners with optimal treatment tools for musculoskeletal injuries in horses. Cell-based therapies require specialized facilities and technical competencies that might not be available or economically justifiable in many private practices. This review provides a summary of current commercially available cell-based therapeutic products for equine applications, their similarities and differences, and current objective data relating to their clinical efficacy.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 363-371 |
| Number of pages | 9 |
| Journal | Veterinary Clinics of North America - Equine Practice |
| Volume | 27 |
| Issue number | 2 |
| DOIs | |
| State | Published - Aug 2011 |
Keywords
- Adipose tissue-derived stromal vascular fraction cells
- Bone marrow aspirate concentrate
- Bone marrow-derived mesenchymal stem cells
- Embryonic-like stem cells
ASJC Scopus subject areas
- Equine
Fingerprint
Dive into the research topics of 'Commercial Cell-based Therapies for Musculoskeletal Injuries in Horses'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS